Delivery Order SPE2DB22D3102-SPE2DB24FL2KP
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML vaccines. The $9,836.34 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 16, 2024, with an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery Contracts...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB20D2014|SPE2DB24FB28J) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,840.23 award has an ultimate completion date of March 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025 to deliver a wide range of pharmaceutical products and...
The federal contract award is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 1, 2024, with a ceiling value of $3,980.24. The contract has an ultimate completion date of November 4, 2024, and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside....
This federal contract award is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML vaccine products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $10,588.80 with a completion date of June 3, 2024. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order with a Firm Fixed Price of $12,652.82 and an ultimate completion date of June 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. This contract is not...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,724.20 firm-fixed-price contract is for the supply of 0.5 mL syringes of the VAXNEUVANCE vaccine. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 24, 2024. The contract has a ceiling value of $16,600.08 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of October 25, 2024. The contract is not...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $7,942.04 to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $15,883.20 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has been awarded numerous pharmaceutical and medical supply contracts by DLA to support military...
This federal contract award is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,207.48 and an ultimate completion date of November 2, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...